Novartis CEO Vas Narasimhan expects the pharmaceutical sector to see tangible AI benefits within 7-10 years, with the company's Hyderabad facility serving as a key innovation hub. The CEO emphasized cost optimization goals and faster medicine delivery through AI technology, while expressing satisfaction with current workforce levels in India. Narasimhan also highlighted the importance of modernizing India's Ayushman Bharat system for broader patient access and revealed significant investments in neuroscience research targeting conditions like Huntington's, Parkinson's, and Alzheimer's disease.
Novartis CEO Vas Narasimhan Expects AI Benefits for Pharmaceutical Sector in 7-10 Years
